You have 9 free searches left this month | for more free features.

Condition

Chronic Hepatitis C Virus (1)

Chronic Hepatitis C Virus Infection (1)

HIV Infections (1)

Hepatitis B (1)

Hepatitis C (1)

Overall Status

Completed (1)

Terminated (1)

Withdrawn (1)

Sign in for free

Phase

phase 2 (3)

Sponsor

Vertex Pharmaceuticals Incorporated (2)

National Institute of Allergy and Infectious Diseases (NIAID) (1)

Collaborator

Intervention

peginterferon-alfa-2a (3)

ribavirin (3)

telaprevir (2)

vx-222 (2)

adefovir dipivoxil (1)

liver biopsy (1)

Study Documents

Intervention Type

drug (3)

biological (2)

procedure (1)

Funder Type

Industry (2)

NIH (1)

Study Type

Interventional (3)

peginterferon-alfa-2a

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

HIV, Hepatitis B, Hepatitis C Trial (Adefovir dipivoxil, Peginterferon-alfa-2A, Ribavirin)

Withdrawn

HIV Infections
+2 more

Adefovir dipivoxil
+3 more

(no location specified)

Oct 28, 2021

Chronic Hepatitis C Virus Infection Trial in New Zealand, United States (telaprevir, VX-222, ribavirin)

Terminated

Chronic Hepatitis C Virus Infection

telaprevir
+3 more

La Jolla, California
+20 more

Sep 22, 2020

Chronic Hepatitis C Virus Trial in Worldwide (VX-222, telaprevir, ribavirin)

Completed

Chronic Hepatitis C Virus

VX-222
+3 more

Birmingham, Alabama
+42 more

Oct 9, 2014